Upload
others
View
8
Download
0
Embed Size (px)
Citation preview
1 COVID-19 CRF V3 dated 28.4.20
Participant ID
Initials of person entering data
Staff email
CONFIDENTIAL CASE REPORT FORM
COVID-19
Series 32
IMPACCT Trials Coordination Centre (ITCC)/
Palliative Care Clinical Studies Collaborative (PaCCSC)
RAPID Pharmacovigilance in Palliative Care
The case report form (CRF) is to be completed in compliance with
ITCC/PaCCSC Standard Operating Procedures (SOP)
2 COVID-19 CRF V3 dated 28.4.20
T0 – Demographics / Co-morbidities Gender: Male Female Other Ethnic Origins
⃝ Oceanian; if yes are they: □ Aboriginal or Torres Strait Is □ Maori □ Other pacific peoples
⃝ Asian
⃝ North America
⃝ Latin American
⃝ North-West European
⃝ Southern and Eastern European
⃝ North African and Middle Eastern
⃝ Sub-Saharan African
Age (yrs)
Weight (kg) if known
Height (cm) if known
Date of first symptoms of COVID-19 – if known:
dd/mm/yyyy
Date of diagnosis of COVID-19 – if known:
dd/mm/yyyy
Was/is patient a smoker: □ Yes □ No
Charlson Comorbidity Index (tick all that apply)
□ Myocardial infarction (history, not ECG
changes only)
□ History of Hypertension
□ Congestive cardiac failure
□ Peripheral vascular disease (includes
aortic aneurysm >= 6 cm)
□ Renal disease □ Liver disease
□ Cerebrovascular disease ,CVA,
hemiplegia
□ Diabetes
□ Dementia □ Chronic pulmonary disease
□ Leukaemia (acute or chronic) □ Lymphoma
□ Any tumour without metastasis (exclude
if > 5 y from diagnosis)
□ Metastatic solid tumour
□ Connective tissue disease □ AIDS (not just HIV positive)
□ Peptic ulcer disease
3 COVID-19 CRF V3 dated 28.4.20
T0 - Baseline Assessment
Date and time of assessment:
dd/mm/yyyy
24hr clock
Place of Care:
⃝ ICU ⃝ Acute hospital ward ⃝ Palliative Care Unit / Hospice
⃝ Emergency department ⃝ Community ⃝ RACF/nursing home ⃝ Hostel/sheltered
accommodation ⃝ Other Australian Modified Karnofsky Performance Scale (AKPS):
100 Normal; no complaints; no evidence of disease
90 Able to carry on normal activity; minor signs of symptoms
80 Normal activity with effort; some signs of symptoms or disease
70 Cares for self; unable to carry on normal activity or to do active work
60 Requires occasional assistance but is able to care for most of his needs
50 Requires considerable assistance and frequent medical care
40 In bed more than 50% of the time
30 Almost completely bedfast
20 Totally bedfast and requiring extensive nursing care by professionals and/or family
10 Comatose or barely rousable
0 Dead
Not able to determine
Most recent laboratory tests (only if available):
Test Value Date taken
D-dimer (ng/ml)
Lymphocyte count ( µL)
Lactic Dehydrogenase (LDH) (U/L)
High sensitivity C-reactive protein (hs-CRP) (mg/L)
Current Oxygen Therapy
Tick if applies
FiO2 (if applicable)
O2 saturations on current therapy
Room air/no oxygen □
O2 via nasal prongs □
O2 via Hudson mask □
02 via rebreather mask □
BiPAP/CPAP □
O2 via high flow nasal prongs □
Ventilated □
4 COVID-19 CRF V3 dated 28.4.20
Patients Temperature: Fahrenheit □ Celsius □
T0 - Baseline Symptom Severity (Palliative Care Outcome Scale) (POS). For each symptom please tick what best describes how it has affected the patient anytime over the last 24 hours. Scoring guide: 0 = Not at all, no effect 1 = Slightly; but not bothered to be rid of the symptom 2 = Moderately; the symptom limits some activity 3 = Severely; activities or concentration markedly affected by symptom 4 = Overwhelmingly affected by symptom; unable to think of anything else
Symptom Not at all
Slightly Moderately Severely Overwhelming Unable to/not
assessed
Breathlessness 0 1 2 3 4 Respiratory secretions 0 1 2 3 4 Fever 0 1 2 3 4 Cough 0 1 2 3 4 Pain 0 1 2 3 4 Shivering 0 1 2 3 4 Sore or dry mouth/throat 0 1 2 3 4 Anxiety 0 1 2 3 4 Depression 0 1 2 3 4 Agitation 0 1 2 3 4 Confusion/Delirium 0 1 2 3 4 Drowsiness 0 1 2 3 4 Weakness/lack of energy 0 1 2 3 4 Diarrhoea 0 1 2 3 4 Constipation 0 1 2 3 4 Nausea 0 1 2 3 4 Vomiting 0 1 2 3 4 Anosmia 0 1 2 3 4 Ageusia 0 1 2 3 4 Other: 0 1 2 3 4
Other symptom 2: 0 1 2 3 4
Other symptom 3: 0 1 2 3 4
Please specify ‘other’ symptom 1 here:
Please specify ‘other’ symptom 2 here:
Please specify ‘other’ symptom 3 here:
5 COVID-19 CRF V3 dated 28.4.20
Please list medications currently being used to treat patient’s symptoms: Medication Which symptom/s are
you treating with this
medication? e.g. pain,
breathlessness,
Dose Frequency e.g. q1h,
q2h, q4h,
Route: e.g. oral,
subcutaneous,
IV, continuous infusion
Is this medication
intended as
sedation? Yes/No
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
6 COVID-19 CRF V3 dated 28.4.20
T1 – Subsequent assessment - 24 hours after baseline, where possible, reflecting back
on the last 12 hours
Date and time of assessment:
dd/mm/yyyy
24hr clock
Place of Care:
⃝ ICU ⃝ Acute hospital ward ⃝ Palliative Care Unit / Hospice
⃝ Emergency department ⃝ Community ⃝ RACF/nursing home
⃝ Hostel/sheltered accommodation ⃝ Other
Australian Modified Karnofsky Performance Scale (AKPS)
100 Normal; no complaints; no evidence of disease
90 Able to carry on normal activity; minor signs of symptoms
80 Normal activity with effort; some signs of symptoms or disease
70 Cares for self; unable to carry on normal activity or to do active work
60 Requires occasional assistance but is able to care for most of his needs
50 Requires considerable assistance and frequent medical care
40 In bed more than 50% of the time
30 Almost completely bedfast
20 Totally bedfast and requiring extensive nursing care by professionals and/or family
10 Comatose or barely rousable
0 Dead
Not able to determine
Current Oxygen Therapy
Tick if applies
FiO2 (if applicable)
O2 saturations on current therapy
Room air/no oxygen □
O2 via nasal prongs □
O2 via Hudson mask □
02 via rebreather mask □
BiPAP/CPAP □
O2 via high flow nasal prongs □
Ventilated □
Patients Temperature: Fahrenheit □ Celsius □
7 COVID-19 CRF V3 dated 28.4.20
Symptom Severity (Palliative Care Outcome Scale) (POS) For each symptom please tick one box that best describes how it has affected the patient anytime over the last 12 hours. Scoring guide: 0 = Not at all, no effect 1 = Slightly; but not bothered to be rid of the symptom 2 = Moderately; the symptom limits some activity 3 = Severely; activities or concentration markedly affected by symptom 4 = Overwhelmingly affected by symptom; unable to think of anything else
Symptom Not at all
Slightly Moderately Severely Overwhelming Unable to/not
assessed
Breathlessness 0 1 2 3 4 Respiratory secretions 0 1 2 3 4 Fever 0 1 2 3 4 Cough 0 1 2 3 4 Pain 0 1 2 3 4 Shivering 0 1 2 3 4 Sore or dry mouth/throat 0 1 2 3 4 Anxiety 0 1 2 3 4 Depression 0 1 2 3 4 Agitation 0 1 2 3 4 Confusion/Delirium 0 1 2 3 4 Drowsiness 0 1 2 3 4 Weakness/lack of energy 0 1 2 3 4 Diarrhoea 0 1 2 3 4 Constipation 0 1 2 3 4 Nausea 0 1 2 3 4 Vomiting 0 1 2 3 4 Anosmia 0 1 2 3 4 Ageusia 0 1 2 3 4 Other: 0 1 2 3 4
Other symptom 2: 0 1 2 3 4
Other symptom 3: 0 1 2 3 4
Please specify ‘other’ symptom 1 here:
Please specify ‘other’ symptom 2 here:
Please specify ‘other’ symptom 3 here:
8 COVID-19 CRF V3 dated 28.4.20
Please list medications used to treat patient’s symptoms in the last 24 hours: Medication Name Which symptom/s are
you treating with this
medication? e.g. pain,
breathlessness,
Dose Frequency e.g. q1h,
q2h, q4h,
or ceased
Route: e.g. oral,
subcutaneous,
IV, continuous infusion
Is this medication
intended as
sedation? Yes/No
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
9 COVID-19 CRF V3 dated 28.4.20
T2 – Subsequent assessment - 48 hours after baseline, where possible, reflecting back
on the last 12 hours
Date and time of assessment:
dd/mm/yyyy
24hr clock
Place of Care:
⃝ ICU ⃝ Acute hospital ward ⃝ Palliative Care Unit / Hospice
⃝ Emergency department ⃝ Community ⃝ RACF/nursing home
⃝ Hostel/sheltered accommodation ⃝ Other
Australian Modified Karnofsky Performance Scale (AKPS):
100 Normal; no complaints; no evidence of disease
90 Able to carry on normal activity; minor signs of symptoms
80 Normal activity with effort; some signs of symptoms or disease
70 Cares for self; unable to carry on normal activity or to do active work
60 Requires occasional assistance but is able to care for most of his needs
50 Requires considerable assistance and frequent medical care
40 In bed more than 50% of the time
30 Almost completely bedfast
20 Totally bedfast and requiring extensive nursing care by professionals and/or family
10 Comatose or barely rousable
0 Dead
Not able to determine
Current Oxygen Therapy
Tick if applies
FiO2 (if applicable)
O2 saturations on current therapy
Room air/no oxygen □
O2 via nasal prongs □
O2 via Hudson mask □
02 via rebreather mask □
BiPAP/CPAP □
O2 via high flow nasal prongs □
Ventilated □
Patients Temperature: Fahrenheit □ Celsius □
10 COVID-19 CRF V3 dated 28.4.20
Symptom Severity (Palliative Care Outcome Scale) (POS) For each symptom please tick one box that best describes how it has affected the patient anytime over the last 12 hours. Scoring guide: 0 = Not at all, no effect 1 = Slightly; but not bothered to be rid of the symptom 2 = Moderately; the symptom limits some activity 3 = Severely; activities or concentration markedly affected by symptom 4 = Overwhelmingly affected by symptom; unable to think of anything else
Symptom Not at
all
Slightly Moderately Severely Overwhelming Unable
to/not assessed
Breathlessness 0 1 2 3 4 Respiratory secretions 0 1 2 3 4 Fever 0 1 2 3 4 Cough 0 1 2 3 4 Pain 0 1 2 3 4 Shivering 0 1 2 3 4 Sore or dry mouth/throat 0 1 2 3 4 Anxiety 0 1 2 3 4 Depression 0 1 2 3 4 Agitation 0 1 2 3 4 Confusion/Delirium 0 1 2 3 4 Drowsiness 0 1 2 3 4 Weakness/lack of energy 0 1 2 3 4 Diarrhoea 0 1 2 3 4 Constipation 0 1 2 3 4 Nausea 0 1 2 3 4 Vomiting 0 1 2 3 4 Anosmia 0 1 2 3 4 Ageusia 0 1 2 3 4 Other: 0 1 2 3 4
Other symptom 2: 0 1 2 3 4
Other symptom 3: 0 1 2 3 4
Please specify ‘other’ symptom 1 here:
Please specify ‘other’ symptom 2 here:
Please specify ‘other’ symptom 3 here:
11 COVID-19 CRF V3 dated 28.4.20
Please list medications used to treat patient’s symptoms in the last 24 hours: Medication Name Which symptom/s are
you treating with this
medication? e.g. pain, breathlessness,
Dose Frequency
e.g. q1h,
q2h, q4h, or ceased
Route: e.g.
oral,
subcutaneous, IV, continuous
infusion
Is this
medication
intended as sedation?
Yes/No 1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
12 COVID-19 CRF V3 dated 28.4.20
Tn - When patient dies OR there is a change in the place of care ⃝ Died – please record date and time of death
dd/mm/yyyy
24hr clock
Place of death ⃝ ICU ⃝ Acute hospital ward ⃝ Palliative Care Unit / Hospice
⃝ Emergency department ⃝ Community ⃝ RACF/nursing home ⃝ Home ⃝ Other Was patient able to have contact with family or loved ones whilst in your care?
⃝ Yes; How was contact made-(tick all that apply).
⃝ Phone
⃝ Face time/Skype/videoconferencing
⃝ In person
⃝ Other; please specify__________________________________
⃝ No: What were the barriers to this? (tick all that apply)
⃝ No access to phone
⃝ No access to Face time/Skype/videoconferencing
⃝ No visitors policy
⃝ No PPE materials
⃝ No space in ward for visitors
⃝ No time/rapid deterioration
⃝ No staff time/capacity
⃝ Other; please specify__________________________________ Any comments to add regarding either death or change in place of care: including any particularly distressing or poorly controlled symptoms in the hours leading up to death; reason for change in place of care etc.
⃝ Patient discharged
dd/mm/yyyy
⃝ Patient transferred/admitted to another place of care
dd/mm/yyyy